Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits The Framingham Offspring Study

被引:128
|
作者
Hivert, Marie-France [1 ,2 ]
Manning, Alisa K. [3 ]
McAteer, Jarred B. [4 ,5 ]
Florez, Jose C. [2 ,4 ,5 ]
Dupuis, Josee [3 ]
Fox, Caroline S. [6 ,7 ]
O'Donnell, Christopher J. [2 ,7 ]
Cupples, L. Adrienne [3 ]
Meigs, James B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res & Diabet Unit, Boston, MA 02114 USA
[5] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[7] NHLBI, Framingham Heart Study, Framingham, MA USA
基金
美国国家卫生研究院;
关键词
D O I
10.2337/db08-0700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Variants in ADIPOQ have been inconsistently associated with adiponectin levels or diabetes. Using comprehensive linkage disequilibrium mapping, we genotyped single nucleotide polymorphisms (SNPs) in ADIPOQ to evaluate the association of common variants with adiponectin levels and risk of diabetes. RESEARCH DESIGN AND METHODS-Participants in the Framingham Offspring Study (n = 2,543, 53% women) were measured for glycemic phenotypes and incident diabetes over 28 years of follow-up; adiponectin levels were quantified at exam 7. We genotyped 22 tag SNPs that captured common (minor allele frequency >0.05) variation at r(2) > 0.8 across ADIPOQ plus 20 kb 5' and 10 kb 3' of the gene. We used linear mixed effects models to test additive associations of each SNP with adiponectin levels and glycemic phenotypes. Hazard ratios (HRs) for incident diabetes were estimated using an adjusted Cox proportional hazards model. RESULTS-Two promoter SNPs in strong linkage disequilibrium with each other (r(2) = 0.80) were associated with adiponectin levels (rs17300539; P-nominal [P-n] 2.6 x 10(-8); P-empiric [P-e] = 0.0005 and rs822387; P-n = 3.8 x 10(-5); P-e = 0.001). A 3'-untranslated region (3'UTR) SNP (rs6773957) was associated with adiponectin levels (P-n = 4.4 x 10(-4); P-e = 0.005). A nonsynonymous coding SNP (rs17366743, Y111H) was confirmed to be associated with diabetes incidence (HR 1.94 [95% CI 1.16-3.25] for the minor C allele; P-n = 0.01) and with higher mean fasting glucose over 28 years of follow-up (P-n = 0.0004; P-e = 0.004). No other significant associations were found with other adiposity and metabolic phenotypes. CONCLUSIONS-Adiponectin levels are associated with SNPs in two different regulatory regions (5' promoter and 3'UTR), whereas diabetes incidence and time-averaged fasting glucose are associated with a missense SNP of ADIPOQ. Diabetes 57: 3353-3359, 2008
引用
收藏
页码:3353 / 3359
页数:7
相关论文
共 50 条
  • [1] Variants in the adiponectin gene (ADIPOQ) are associated with adiponectin levels and type 2 diabetes or glycemic traits: The Framingham Offspring Study
    Hivert, Marie-France
    Manning, Lisa K.
    Florez, Jose C.
    Dupuis, Josee
    Fox, Caroline S.
    Cupples, L. Adrienne
    Meigs, James B.
    DIABETES, 2008, 57 : A335 - A336
  • [2] Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study
    Hivert, Marie-France
    Manning, Alisa K.
    McAteer, Jarred B.
    Dupuis, Josee
    Fox, Caroline S.
    Cupples, L. Adrienne
    Meigs, James B.
    Florez, Jose C.
    DIABETES, 2009, 58 (03) : 750 - 756
  • [3] Plasma adiponectin levels, ADIPOQ variants, and incidence of type 2 diabetes: A nested case-control study
    Goto, Atsushi
    Noda, Mitsuhiko
    Goto, Maki
    Yasuda, Kazuki
    Mizoue, Tetsuya
    Yamaji, Taiki
    Sawada, Norie
    Iwasaki, Motoki
    Inoue, Manami
    Tsugane, Shoichiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 127 : 254 - 264
  • [4] Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians
    Vendramini, Marcio F.
    Pereira, Alexandre C.
    Ferreira, Sandra R.
    Kasamatsu, Teresa S.
    Moises, Regina S.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (02) : 115 - 120
  • [5] Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study
    Siitonen, Niina
    Pulkkinen, Leena
    Lindstrom, Jaana
    Kolehmainen, Marjukka
    Eriksson, Johan G.
    Venojarvi, Mika
    Ilanne-Parikka, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Tuomilehto, Jaakko
    Uusitupa, Matti
    BMC MEDICAL GENETICS, 2011, 12
  • [6] Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
    Ramya, Kandaswamy
    Ayyappa, Kuppuswamy Ashok
    Ghosh, Saurabh
    Mohan, Viswanathan
    Radha, Venkatesan
    GENE, 2013, 532 (02) : 253 - 262
  • [7] The relationship between circulating adiponectin, ADIPOQ variants and incident cardiovascular disease in type 2 diabetes: The Fremantle Diabetes Study
    Peters, Kirsten E.
    Davis, Wendy A.
    Beilby, John
    Hung, Joe
    Bruce, David G.
    Davis, Timothy M. E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 62 - 70
  • [8] Glycated albumin and adiponectin levels in type 2 diabetes and coronary heart disease: Results from the Framingham Offspring Study
    Ai, Masumi
    Otokozawa, Seiko
    Asztalos, Bela F.
    White, Charles C.
    Demissie-Banjaw, Serkalem
    Cupples, Ladrienne
    Nakajima, Katsuyuki
    Schaefer, Ernst J.
    DIABETES, 2008, 57 : A272 - A273
  • [9] Variants of the adiponectin gene and type 2 diabetes in a Polish population
    Magdalena Szopa
    Malgorzata Malczewska-Malec
    Beata Wilk
    Jan Skupien
    Pawel Wolkow
    Maciej T. Malecki
    Jacek Sieradzki
    Acta Diabetologica, 2009, 46 : 317 - 322
  • [10] Variants of the adiponectin gene and type 2 diabetes in a Polish population
    Szopa, Magdalena
    Malczewska-Malec, Malgorzata
    Wilk, Beata
    Skupien, Jan
    Wolkow, Pawel
    Malecki, Maciej T.
    Sieradzki, Jacek
    ACTA DIABETOLOGICA, 2009, 46 (04) : 317 - 322